Sacral Neuromodulation in the Management of Refractory Pediatric Lower Urinary Tract Dysfunction
Neurourology and Urodynamics · 2026-09 · 45 (7) · 1366-1372
DOI: 10.1002/nau.70365 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Neurourology and Urodynamics, online erschienen am 06.07.2026. Verfasst von Megan A Stout und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee, USA. Hauptthemen laut MEDLINE: Lower Urinary Tract Symptoms, Electric Stimulation Therapy, Lumbosacral Plexus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Sacral neuromodulation is currently used in the pediatric patient population for refractory lower urinary tract dysfunction (LUTD). Evidence, however, is currently limited for institutional experiences of long‐term outcomes for sacral neuromodulation in the pediatric patient population.
Objective
The objective of this study is to perform a retrospective review of a large multi‐institutional cohort of pediatric patients that underwent sacral neuromodulation (SNM) for refractory LUTD, focused on rates of symptom improvement, quality of life, and bowel‐bladder dysfunction measures following device implantation. Secondary objectives included assessing device complication rates and device removals due to failure or successful resolution of symptoms.
Methods
We performed a retrospective cohort study of pediatric patients at three children's hospitals that underwent SNM device implantation for refractory LUTD. Patients 4–18 years of age who were diagnosed with refractory LUTD and managed at a participating institution with follow‐up were included. Outcomes were evaluated at baseline and post‐operatively after two‐stage device implantation at initial follow‐up and annually until device removal or final follow‐up.
Results
From 2010 to 2022, a total of 205 children underwent SNM procedures at three pediatric hospital centers. 204 patients completed the two‐stage procedure for permanent device implantation with a median follow‐up of 3.4 years (1.3, 4.9). One hundred seventy‐eight patients reported partial (25%) or complete (54%) device response/symptom improvement by final follow‐up. Comparison of patient‐reported validated questionnaires completed at baseline and by final follow‐up visit revealed significant improvement in median Pediatric Quality of Life Inventory (PedsQL) ( p = 0.004) and Vancouver Nonneurogenic Lower Urinary Tract Dysfunction/Dysfunctional Elimination Syndrome bowel‐bladder dysfunction (BBD) scores ( p < 0.001). Of those with any device complication ( n = 43;21%), 19 patients required device revision, and 20 required complete device removal. Separately, twenty‐eight patients (13%) underwent device removal due to resolution of symptoms or treatment success at a median period of 5 years (4,7).
Conclusion
SNM use demonstrated a majority of patients reporting at least partial subjective symptom improvement following device implantation across multiple institutions by final follow‐up. SNM is a viable treatment option for refractory LUTD in the pediatric patient if willing to undergo an invasive procedure and in which thorough counseling of risks and benefits has occurred.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
- Department of Pediatric Urology, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Biostatistics, Vanderbilt University, Nashville, Tennessee, USA.
- Center for Surgical Outcomes Research, Nationwide Children's Hospital, Abigail Wexner Research Institute, Columbus, Ohio, USA.
- Department of Pediatric Urology, James Whitcomb Riley Children's Hospital, Indianapolis, Indiana, USA.
ORCID-Profile: Megan A Stout, Tatsuki Koyama, Seth A Alpert
Zitieren
APA
Stout, M. A., Corona, L. E., Huang, L. C., Koyama, T., Gil, L. A., King, S., Whittam, B. M., Alpert, S. A., & Pope, J. C. (2026). Sacral Neuromodulation in the Management of Refractory Pediatric Lower Urinary Tract Dysfunction. Neurourology and Urodynamics, 45(7), 1366-1372. https://doi.org/10.1002/nau.70365
Vancouver
Stout MA, Corona LE, Huang LC, Koyama T, Gil LA, King S, et al. Sacral Neuromodulation in the Management of Refractory Pediatric Lower Urinary Tract Dysfunction. Neurourology and Urodynamics. 2026;45(7):1366-1372. doi:10.1002/nau.70365
BibTeX
@article{Stout2026,
author = {Stout, Megan A and Corona, Lauren E and Huang, Li-Ching and Koyama, Tatsuki and Gil, Lindsay A and King, Shelly and Whittam, Benjamin M and Alpert, Seth A and Pope, John C},
title = {Sacral Neuromodulation in the Management of Refractory Pediatric Lower Urinary Tract Dysfunction},
journal = {Neurourology and Urodynamics},
year = {2026},
volume = {45},
number = {7},
pages = {1366--1372},
doi = {10.1002/nau.70365}
}
EUVIMED